Skip to content

Schrodinger SDGR EBITDA margin

EBITDA margin at other companies

Cadence Design Systems logo
Cadence Design SystemsCDNS
32.9%-1.4pp
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
-754.8%-93.5pp
Absci Corporation logo
Absci CorporationABSI
-6,102.2%-12,621pp
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-237.8%-104pp
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-2,749.9%-808pp
Certara, Inc. logo
Certara, Inc.CERT
20.2%

Other financials

Income statement

See full
Revenue$58.6M-1.6%
Gross profit$29.5M-5.1%
Operating income-$48.8M+4.1%
Net income-$60.0M-0.4%
EPS (diluted)-$0.81+1.2%

Balance sheet

See full
Cash & equivalents$267.7M-20.7%
Total debt$107.0M-7.9%
Total equity$313.5M-16.1%
Total assets$634.2M-14.6%

Cash flow

See full
Operating cash flow-$14.8M-110%
CapEx$2.5M+321%
Free cash flow-$17.3M-112%

Valuation

See full
Market cap$1.15B-23.7%
Enterprise value$984.71M-23.1%
P/S4.5×-2.0×

Profitability

See full
Gross margin55.3%-7.3pp
Operating margin-64.7%-12.0pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.7×

Where this comes from

Calculated from Schrodinger’s reported figures.

Based on trailing twelve months.

The official record: Schrodinger’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schrodinger's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schrodinger's EBITDA margin?
Schrodinger (SDGR) reported EBITDA margin of -62.3% in Q1 2026.
How has Schrodinger's EBITDA margin changed year-over-year?
Schrodinger's EBITDA margin increased by 22.9% year-over-year, from -80.9% to -62.3%.
What is the long-term trend for Schrodinger's EBITDA margin?
Over 5 years (2020 to 2025), Schrodinger's EBITDA margin has grown at a 3.5% compound annual growth rate (CAGR), from -53% to -62.9%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.